A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis
Clinical trial NCT05276011 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05276011
- Sponsor
- Kolon TissueGene, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-10-01
- Primary completion
- 2028-10-01
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.